Management of Temporary Transvenous Pacemakers
Patient Assessment
- The American College of Cardiology recommends documenting symptoms of bradycardia, including syncope, presyncope, altered mental status, ischemic chest discomfort, acute heart failure signs, hypotension, or signs of shock in patients with temporary transvenous pacemakers 1
- The American Society of Anesthesiologists (ASA) suggests assessing pacing dependency by history of symptomatic bradyarrhythmia requiring pacemaker implantation, history of successful atrioventricular nodal ablation, or inadequate escape rhythm at lowest programmable pacing rate 2
- The European Heart Journal recommends identifying reversible causes, such as recent cardiac surgery, myocardial infarction, medication effects, electrolyte abnormalities, or myocarditis, in patients with temporary transvenous pacemakers 3, 1
Pacemaker Management
- The American College of Cardiology recommends verifying pacemaker function, including electrical capture, mechanical capture, and sensing function, in patients with temporary transvenous pacemakers 1, 2
- The American Society of Anesthesiologists (ASA) suggests optimizing pacemaker settings, including maintaining a rate of 60-80 bpm for hemodynamic stability and adjusting sensitivity to prevent oversensing 2, 5
- The American College of Cardiology recommends considering externalized permanent active fixation lead if prolonged temporary pacing is required (>24-48 hours) (Class IIa) 1, 7
Complications and Troubleshooting
- The Praxis Medical Insights guidelines report a lead dislodgement risk of 16% (50% within the first 24 hours) and an increased infection risk with prolonged temporary pacing 5
- The American Society of Anesthesiologists (ASA) recommends troubleshooting common problems, including loss of capture, oversensing, and undersensing, by adjusting pacemaker settings and verifying lead-generator connection 2, 5
Disposition and Follow-up
- The American College of Cardiology recommends cardiology consultation for permanent pacemaker evaluation if conduction disease persists beyond reversible cause treatment 1
- The Circulation journal suggests continuing telemetry monitoring until the temporary pacemaker is removed or replaced with a permanent device 6, 5